Status:
COMPLETED
Anodal tDCS in Chronic Migraine With Medication Overuse
Lead Sponsor:
IRCCS National Neurological Institute "C. Mondino" Foundation
Collaborating Sponsors:
University of Pavia
Conditions:
Chronic Migraine
Medication Overuse Headache
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Non-invasive neuromodulation has been applied in several forms of primary headaches, and its usefulness has been suggested for both episodic and chronic migraine (CM). Transcranial direct current stim...
Detailed Description
The study was a randomized, double-blind, controlled trial aimed at assessing the efficacy of five daily sessions of anodal t-DCS in add-on to a standardized in-hospital detoxification protocol in pat...
Eligibility Criteria
Inclusion
- age 18 to 65 years;
- chronic migraine according to the criteria of the InternationaI Classification of Headache Disorders (code 1.3 ICHD-III) and Medication Overuse Headache (code 8.2 ICHD-III) present for at least 6 months at inclusion;
- previous failure of at least three prophylactic treatments.
Exclusion
- other neurologic or neuropsychiatric diseases;
- other chronic painful syndromes;
- other types of primary or secondary headaches;
- use of a preventive medication at baseline;
- use of central nervous system modulating drugs;
- epilepsy;
- metallic head implants or use of a cardiac pacemaker;
- pregnancy or lactation.
Key Trial Info
Start Date :
January 15 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 15 2018
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04336267
Start Date
January 15 2015
End Date
January 15 2018
Last Update
April 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.